Large-scale silane bead-based SARS-CoV-2 testing of a nursing home in Spain identifies a viral reservoir during lockdown period
Weber, N.; Goni-Salaverri, A.; Rodriguez, J. A.; Unfried, J. P.; Alameda, D.; Fernandez-Alonso, M.; Saez, E.; Maestro-Galilea, S.; Alegre, F.; Carmona-Torre, F.; Marin-Oto, M.; Olague, C.; Odriozola, L.; Navarro-Alonso, M.; Sanchez-Ostiz, R.; Argemi, J.; del Pozo, J. L.; LARA-ASTIASO, D.
Show abstract
Background: Spain is one of the countries most heavily affected by the COVID-19 pandemic. As in other countries such as UK and USA, nursing homes have been an important human reservoir for the virus and the population with the highest mortality worldwide. The presence of asymptomatic carriers within nursing homes is one of the factors that could provoke new outbreaks during the relaxing of lockdown measures. Methods: We developed a high-throughput protocol for RNA extraction of patient samples based on silane magnetic beads in multi-well plates. The sensitivity, specificity and reproducibility rates were assessed using positive and negative clinical samples from the Clinica Universidad de Navarra, Spain. We utilized the protocol to test a pilot cohort of 138 residents and 87 staff from a nursing home in Northern Navarre, Spain. Findings: Our protocol showed high sensitivity (100%), specificity (96.0%) and linear correlation with PCR cycle threshold values obtained with a standard testing kit (R2 = 0.807, p=3E-05). Testing of 225 individuals from the nursing home revealed 63 residents (46%) and 14 staff (16%) positive for SARS-CoV-2. Only 18 of the positive residents (28.6%) were symptomatic at time of testing. During follow-up, six PCR-negative symptomatic residents were retested and resulted positive. One-month mortality among positive residents was higher than in negative residents (15.9% vs 1.3%), regardless of age or comorbidities. Interpretation: Rapid silane bead-based RNA extraction expanded the testing capabilities and COVID-19 patients were promptly identified. Personal and public health measures were enacted to avoid spreading and tighten clinical surveillance. The ability to easily adapt the technical capabilities of academic research centers to large-scale testing for SARS-CoV-2 could provide an invaluable tool for ensuring a safe lifting of lockdown in countries with high numbers of cases.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Safe and effective pool testing for SARS-CoV-2 detection 94%
- Is the glass half full? Extraction-free RT-LAMP to detect SARS-CoV-2 is less sensitive but highly specific compared to standard RT-PCR in 101 samples 94%
- CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical setting 93%
Similar papers in this journal
- Validation of a rapid, saliva-based, and ultra-sensitive SARS-CoV-2 screening system for a pandemic-scale infection surveillance 95%
- Sensitive detection and quantification of SARS-CoV-2 in saliva 94%
- VarLOCK - sequencing independent, rapid detection of SARS-CoV-2 variants of concern for point-of-care testing, qPCR pipelines and national wastewater surveillance 94%
Similar papers in this journal
- Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests 93%
- Large-scale implementation of pooled RNA-extraction and RT-PCR for SARS-CoV-2 detection 93%
- Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for the diagnosis of COVID-19 in primary healthcare centers 93%
Similar papers in this journal
- Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights 94%
- Clinical Performance of Direct RT-PCR Testing of Raw Saliva for Detection of SARS-CoV-2 in Symptomatic and Asymptomatic Individuals 93%
- Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test in symptomatic populations and asymptomatic community testing 93%
Similar papers in this journal
- Versatile and flexible microfluidic qPCR test for high-throughput SARS-CoV-2 and cellular response detection in nasopharyngeal swab samples 95%
- High throughput SARS-CoV-2 variant analysis using molecular barcodes coupled with Next Generation Sequencing 94%
- Diagnostic accuracy of two commercial SARS-CoV-2 Antigen-detecting rapid tests at the point of care in community-based testing centers 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.